Pacgen Biopharmaceuticals Corporation (pga) - Financial And Strategic Analysis Review - Aarkstore

Aarkstore announce a new report "Pacgen Biopharmaceuticals Corporation (PGA) - Financial

and Strategic Analysis Review" through its vast collection of market research report.

Pacgen Biopharmaceuticals Corporation (Pacgen) is a publicly held Canada-based life sciences company. The company is principally engaged in the development of therapeutics which can treat infectious and inflammatory diseases. The companys developmental pipeline includes, PAC-113, an anti-fungal in a phase II program for the treatment of oral candidiasis and PAC-G31P, a peptide therapeutic being investigated in preclinical studies for its potential to treat inflammatory disease. The company also has PAC-527 and PAC-745 in early stage of development.

Pacgen Biopharmaceuticals Corporation Key Recent Developments

Jan 28, 2010: Pacgen Forms R&D Collaboration With New Summit Biopharma

Aug 13, 2009: Pacgen Completes Acquisition Of Xphase

This comprehensive SWOT profile of Pacgen Biopharmaceuticals Corporation provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, the highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Pacgen Biopharmaceuticals Corporation, including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days (excluding weekends).

The profile contains critical company information including*,

- Business description A detailed description of the companys operations and business divisions.

- Corporate strategy Analysts summarization of the companys business strategy.

- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.

- Company history Progression of key events associated with the company.

- Major products and services A list of major products, services and brands of the company.

- Key competitors A list of key competitors to the company.

- Key employees A list of the key executives of the company.

- Executive biographies A brief summary of the executives employment history.

- Key operational heads A list of personnel heading key departments/functions.

- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

For more information, please visit:

http://www.aarkstore.com/reports/Pacgen-Biopharmaceuticals-Corporation-PGA-Financial-and-Strategic-Analysis-Review-50255.html

Or email us at press@aarkstore.com or call +919272852585

by: Aarkstore Enterprise

POST COMMENT

Paion Ag (pa8) - Financial And Strategic Analysis Review - Aarkstore Enterprise Canadian Orebodies, Inc. (co) - Financial And Strategic Analysis Review - Aarkstore Enterprise Parexel International Corporation (prxl) - Financial And Strategic Analysis Review - Aarkstore Patrys Limited (pab) - Financial And Strategic Analysis Review - Aarkstore Enterprise Conjuchem Biotechnologies Inc. (cjb) - Financial And Strategic Analysis Review - Aarkstore Enterpris Medigen Biotechnology Corp. (3176) - Financial And Strategic Analysis Review - Aarkstore Enterprise Cosmo Pharmaceuticals S.p.a (copn) - Financial And Strategic Analysis Review - Aarkstore Enterprise Peplin, Inc. (pli) - Financial And Strategic Analysis Review - Aarkstore Enterprise Peregrine Pharmaceuticals, Inc. (pphm) - Financial And Strategic Analysis Review - Aarkstore Critical Outcome Technologies Inc. (cot) - Financial And Strategic Analysis Review - Aarkstore Pharmanet Group Ltd (pno) - Financial And Strategic Analysis Review - Aarkstore Enterprise all natural soap, soap lye, making bath salt, wholesale bath salt Pharmasset, Inc (vrus) - Financial And Strategic Analysis Review - Aarkstore Enterprise